Lexicon Pharmaceuticals
$4.699876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$4.69
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.18 (-3.70%) As of 1:17 PM EST today
-$0.18 (-3.70%) Today
Why Robinhood?
You can buy or sell LXRX and other stocks, options, ETFs, and crypto commission-free!
About LXRX
Lexicon Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of pharmaceutical products for the treatment of human disease. It drug candidates include XERMELO, Sotagliflozin, LX2761, and LX9211. Read More The company was founded by Brian P. Zambrowicz and Arthur T. Sands on July 7, 1995 and is headquartered in The Woodlands, TX.
CEO
Employees
202
Headquarters
The Woodlands, Texas
Founded
1995
Market Cap
449.53M
Price-Earnings Ratio
3.56
Dividend Yield
0.00
Average Volume
2.04M
High Today
$5.20
Low Today
$4.67
Open Price
$5.00
Volume
1.75M
52 Week High
$8.39
52 Week Low
$1.13
Collections
LXRX Earnings
-$0.43
-$0.04
$0.34
$0.73
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Estimated
—
Actual
Expected Mar 11, Pre-Market